A Randomized Trial Comparing Suprachoroidal and Intravitreal Injection of Triamcinolone Acetonide in Refractory Diabetic Macular Edema due to Epiretinal Membrane
Purpose. To compare the efficacy and safety of suprachoroidal and intravitreal injection of triamcinolone acetonide in pseudophakic patients with refractory diabetic macular edema (DME) due to epiretinal membrane (ERM). Study Design. This study is a randomized clinical trial (RCT). Participants. Twe...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Hindawi Limited
2022-01-01
|
| Series: | Journal of Ophthalmology |
| Online Access: | http://dx.doi.org/10.1155/2022/7947710 |
| _version_ | 1827000612983668736 |
|---|---|
| author | Ahmed Abdelshafy Tabl Tarek Tawfik Soliman Mohamed Anany Elsayed Marwa Abdelshafy Tabl |
| author_facet | Ahmed Abdelshafy Tabl Tarek Tawfik Soliman Mohamed Anany Elsayed Marwa Abdelshafy Tabl |
| author_sort | Ahmed Abdelshafy Tabl |
| collection | DOAJ |
| description | Purpose. To compare the efficacy and safety of suprachoroidal and intravitreal injection of triamcinolone acetonide in pseudophakic patients with refractory diabetic macular edema (DME) due to epiretinal membrane (ERM). Study Design. This study is a randomized clinical trial (RCT). Participants. Twenty-three nonvitrectomized pseudophakic eyes of 23 subjects (9 M and 14 F with mean age: 54.8 years) with refractory DME due to ERM. Methods. The eyes were randomized to suprachoroidal triamcinolone acetonide injection 4 mg/0.1 ml (SCTA) (n = 13 eyes) or intravitreal triamcinolone acetonide 4 mg/0.1 ml (IVTA) (n = 10 eyes) and were evaluated at baseline and 1 and 3 months after injection to assess outcome measures. Main Outcome Measures. Changes in best-corrected visual acuity (BCVA) (primary outcome), central foveal thickness (CFT) by optical coherence tomography (OCT), and intraocular pressure (IOP) measurement (secondary). Results. Baseline median BCVA (logMAR) was 1.0 (range 0.8–1.0) in both groups, improved within the SCTA group to 0.8 on the 1st and 3rd months, while in the IVTA group, median BCVA changed to 0.8 and 0.9 on the 1st and 3rd months, respectively. No significant differences were noted between groups regarding BCVA at baseline (P=0.927), and 1st (P=0.605) and 3rd months (P=0.313). Regarding mean CFT, no significant differences were observed at baseline (P=0.353) and at the first month (P=0.214) between both groups, while at the third month, CFT was significantly higher in the IVTA group (385 um) than in the SCTA group (323 um) (P=0.028). Mean IOP was significantly higher in the IVTA group (15 mmHg) on 1st month than in the SCTA group (12 mmHg) (P=0.011); after 3rd month, IOP was significantly higher within the IVTA group (18 mmHg) than SCTA (14 mmHg) (P=0.028). No significant difference was noted between both groups at baseline IOP (P=0.435). Conclusions. Both SCTA and IVTA are effective in reduction of CFT and improvement of patients’ visual acuity, but with a higher recurrence rate and rise in IOP after IVTA when compared to SCTA. Both treatments have temporary effects with the possibility of recurrence of DME and the need for retreatment. |
| first_indexed | 2024-04-11T18:08:49Z |
| format | Article |
| id | doaj.art-77a20472311346a2a36549d53c0d3cf9 |
| institution | Directory Open Access Journal |
| issn | 2090-0058 |
| language | English |
| last_indexed | 2025-02-18T10:46:55Z |
| publishDate | 2022-01-01 |
| publisher | Hindawi Limited |
| record_format | Article |
| series | Journal of Ophthalmology |
| spelling | doaj.art-77a20472311346a2a36549d53c0d3cf92024-11-02T05:27:16ZengHindawi LimitedJournal of Ophthalmology2090-00582022-01-01202210.1155/2022/7947710A Randomized Trial Comparing Suprachoroidal and Intravitreal Injection of Triamcinolone Acetonide in Refractory Diabetic Macular Edema due to Epiretinal MembraneAhmed Abdelshafy Tabl0Tarek Tawfik Soliman1Mohamed Anany Elsayed2Marwa Abdelshafy Tabl3Department of OphthalmologyDepartment of OphthalmologyDepartment of OphthalmologyDepartment of OphthalmologyPurpose. To compare the efficacy and safety of suprachoroidal and intravitreal injection of triamcinolone acetonide in pseudophakic patients with refractory diabetic macular edema (DME) due to epiretinal membrane (ERM). Study Design. This study is a randomized clinical trial (RCT). Participants. Twenty-three nonvitrectomized pseudophakic eyes of 23 subjects (9 M and 14 F with mean age: 54.8 years) with refractory DME due to ERM. Methods. The eyes were randomized to suprachoroidal triamcinolone acetonide injection 4 mg/0.1 ml (SCTA) (n = 13 eyes) or intravitreal triamcinolone acetonide 4 mg/0.1 ml (IVTA) (n = 10 eyes) and were evaluated at baseline and 1 and 3 months after injection to assess outcome measures. Main Outcome Measures. Changes in best-corrected visual acuity (BCVA) (primary outcome), central foveal thickness (CFT) by optical coherence tomography (OCT), and intraocular pressure (IOP) measurement (secondary). Results. Baseline median BCVA (logMAR) was 1.0 (range 0.8–1.0) in both groups, improved within the SCTA group to 0.8 on the 1st and 3rd months, while in the IVTA group, median BCVA changed to 0.8 and 0.9 on the 1st and 3rd months, respectively. No significant differences were noted between groups regarding BCVA at baseline (P=0.927), and 1st (P=0.605) and 3rd months (P=0.313). Regarding mean CFT, no significant differences were observed at baseline (P=0.353) and at the first month (P=0.214) between both groups, while at the third month, CFT was significantly higher in the IVTA group (385 um) than in the SCTA group (323 um) (P=0.028). Mean IOP was significantly higher in the IVTA group (15 mmHg) on 1st month than in the SCTA group (12 mmHg) (P=0.011); after 3rd month, IOP was significantly higher within the IVTA group (18 mmHg) than SCTA (14 mmHg) (P=0.028). No significant difference was noted between both groups at baseline IOP (P=0.435). Conclusions. Both SCTA and IVTA are effective in reduction of CFT and improvement of patients’ visual acuity, but with a higher recurrence rate and rise in IOP after IVTA when compared to SCTA. Both treatments have temporary effects with the possibility of recurrence of DME and the need for retreatment.http://dx.doi.org/10.1155/2022/7947710 |
| spellingShingle | Ahmed Abdelshafy Tabl Tarek Tawfik Soliman Mohamed Anany Elsayed Marwa Abdelshafy Tabl A Randomized Trial Comparing Suprachoroidal and Intravitreal Injection of Triamcinolone Acetonide in Refractory Diabetic Macular Edema due to Epiretinal Membrane Journal of Ophthalmology |
| title | A Randomized Trial Comparing Suprachoroidal and Intravitreal Injection of Triamcinolone Acetonide in Refractory Diabetic Macular Edema due to Epiretinal Membrane |
| title_full | A Randomized Trial Comparing Suprachoroidal and Intravitreal Injection of Triamcinolone Acetonide in Refractory Diabetic Macular Edema due to Epiretinal Membrane |
| title_fullStr | A Randomized Trial Comparing Suprachoroidal and Intravitreal Injection of Triamcinolone Acetonide in Refractory Diabetic Macular Edema due to Epiretinal Membrane |
| title_full_unstemmed | A Randomized Trial Comparing Suprachoroidal and Intravitreal Injection of Triamcinolone Acetonide in Refractory Diabetic Macular Edema due to Epiretinal Membrane |
| title_short | A Randomized Trial Comparing Suprachoroidal and Intravitreal Injection of Triamcinolone Acetonide in Refractory Diabetic Macular Edema due to Epiretinal Membrane |
| title_sort | randomized trial comparing suprachoroidal and intravitreal injection of triamcinolone acetonide in refractory diabetic macular edema due to epiretinal membrane |
| url | http://dx.doi.org/10.1155/2022/7947710 |
| work_keys_str_mv | AT ahmedabdelshafytabl arandomizedtrialcomparingsuprachoroidalandintravitrealinjectionoftriamcinoloneacetonideinrefractorydiabeticmacularedemaduetoepiretinalmembrane AT tarektawfiksoliman arandomizedtrialcomparingsuprachoroidalandintravitrealinjectionoftriamcinoloneacetonideinrefractorydiabeticmacularedemaduetoepiretinalmembrane AT mohamedananyelsayed arandomizedtrialcomparingsuprachoroidalandintravitrealinjectionoftriamcinoloneacetonideinrefractorydiabeticmacularedemaduetoepiretinalmembrane AT marwaabdelshafytabl arandomizedtrialcomparingsuprachoroidalandintravitrealinjectionoftriamcinoloneacetonideinrefractorydiabeticmacularedemaduetoepiretinalmembrane AT ahmedabdelshafytabl randomizedtrialcomparingsuprachoroidalandintravitrealinjectionoftriamcinoloneacetonideinrefractorydiabeticmacularedemaduetoepiretinalmembrane AT tarektawfiksoliman randomizedtrialcomparingsuprachoroidalandintravitrealinjectionoftriamcinoloneacetonideinrefractorydiabeticmacularedemaduetoepiretinalmembrane AT mohamedananyelsayed randomizedtrialcomparingsuprachoroidalandintravitrealinjectionoftriamcinoloneacetonideinrefractorydiabeticmacularedemaduetoepiretinalmembrane AT marwaabdelshafytabl randomizedtrialcomparingsuprachoroidalandintravitrealinjectionoftriamcinoloneacetonideinrefractorydiabeticmacularedemaduetoepiretinalmembrane |